162 related articles for article (PubMed ID: 23295545)
1. Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
Chello M; Spadaccio C
Cardiology; 2013; 124(1):36-7. PubMed ID: 23295545
[No Abstract] [Full Text] [Related]
2. CORONA, statins, and heart failure: who lost the crown?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
[No Abstract] [Full Text] [Related]
3. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.
Andreou I; Tousoulis D; Miliou A; Tentolouris C; Zisimos K; Gounari P; Siasos G; Papageorgiou N; Papadimitriou CA; Dimopoulos MA; Stefanadis C
Atherosclerosis; 2010 May; 210(1):194-8. PubMed ID: 19962701
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin in older patients with systolic heart failure.
Florkowski CM; Molyneux SL; George PM
N Engl J Med; 2008 Mar; 358(12):1301; author reply 1301. PubMed ID: 18354111
[No Abstract] [Full Text] [Related]
6. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
Serebruany VL
Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
[No Abstract] [Full Text] [Related]
7. Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?
Mori K; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S; Yoshida K
Clin Immunol; 2009 Mar; 130(3):375-7. PubMed ID: 19019736
[No Abstract] [Full Text] [Related]
8. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Panza F
J Am Geriatr Soc; 2008 Jul; 56(7):1366-7. PubMed ID: 18774975
[No Abstract] [Full Text] [Related]
9. [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
Ohfuji K; Yano S; Yamaguchi M; Smith G; Hirata M; Shimada H; Izuishi K; Shinagawa J; Matsunaga K
Nihon Yakurigaku Zasshi; 2005 Sep; 126(3):213-9. PubMed ID: 16272766
[No Abstract] [Full Text] [Related]
10. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
[TBL] [Abstract][Full Text] [Related]
11. Statin, the black box.
Hatem S; Boccara F
Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
[No Abstract] [Full Text] [Related]
12. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
Takagi H; Umemoto T
Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
[No Abstract] [Full Text] [Related]
13. Coenzyme Q10 and statins in heart failure: the dog that didn't bark.
Felker GM
J Am Coll Cardiol; 2010 Oct; 56(15):1205-6. PubMed ID: 20883927
[No Abstract] [Full Text] [Related]
14. Statins for ischemic systolic heart failure.
Masoudi FA
N Engl J Med; 2007 Nov; 357(22):2301-4. PubMed ID: 17984167
[No Abstract] [Full Text] [Related]
15. Abstracts of the XV International Symposium on Drugs Affecting Lipid Metabolism, 24-27 October, 2004, Venice, Italy.
Int J Clin Pract Suppl; 2005 Jun; (148):3-16. PubMed ID: 15885073
[No Abstract] [Full Text] [Related]
16. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
[TBL] [Abstract][Full Text] [Related]
17. CORONA study highlights challenges of treating older patients with systolic heart failure.
Cardiovasc J Afr; 2007; 18(6):402-4. PubMed ID: 18092121
[No Abstract] [Full Text] [Related]
18. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin and cardiovascular continuum when time is important.
Barrios V; Escobar C
J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
[No Abstract] [Full Text] [Related]
20. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
Nicholls SJ; Uno K; Kataoka Y
Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
